白介素6受体基因变异与克罗恩病及溃疡性结肠炎风险相关
基于全基因组荟萃分析(20,550例克罗恩病患者、17,647例溃疡性结肠炎患者及超过40,000例无炎症性肠病对照),研究发现IL6R单核苷酸多态性rs2228145(按可溶性IL6R水平升高2倍标化)与克罗恩病风险降低相关(比值比0.876;95%置信区间0.822-0.933;P=0.00003),也与溃疡性结肠炎风险降低相关(比值比0.932;95%置信区间0.875-0.996;P=0.036)。作者认为靶向阻断IL6R信号的治疗可能对炎症性肠病有效。
要点
- IL6R变异rs2228145与可溶性IL6R水平升高相关,并关联炎症性疾病风险降低。
- 该变异与克罗恩病风险降低相关:比值比0.876(95%置信区间0.822-0.933;P=0.00003)。
- 该变异与溃疡性结肠炎风险降低相关:比值比0.932(95%置信区间0.875-0.996;P=0.036)。
核心结论
- IL6R信号减弱与克罗恩病及溃疡性结肠炎风险降低相关,作者认为靶向阻断IL6R信号的治疗可能对炎症性肠病有效。
研究设计与样本
- 全基因组荟萃分析,纳入20,550例克罗恩病患者、17,647例溃疡性结肠炎患者及超过40,000例无炎症性肠病对照。
主要发现
- rs2228145(按可溶性IL6R水平升高2倍标化)与克罗恩病风险降低相关:比值比0.876;95%置信区间0.822-0.933;P=0.00003。
- rs2228145(按可溶性IL6R水平升高2倍标化)与溃疡性结肠炎风险降低相关:比值比0.932;95%置信区间0.875-0.996;P=0.036。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interleukin 6 (IL6) is an inflammatory cytokine; signaling via its receptor (IL6R) is believed to contribute to development of inflammatory bowel diseases (IBD). The single nucleotide polymorphism rs2228145 in IL6R associates with increased levels of soluble IL6R (s-IL6R), as well as reduced IL6R signaling and risk of inflammatory disorders; its effects are similar to those of a therapeutic monoclonal antibody that blocks IL6R signaling. We used the effect of rs2228145 on s-IL6R level as an indirect marker to investigate whether reduced IL6R signaling associates with risk of ulcerative colitis (UC) or Crohn's disease (CD). In a genome-wide meta-analysis of 20,550 patients with CD, 17,647 patients with UC, and more than 40,000 individuals without IBD (controls), we found that rs2228145 (scaled to a 2-fold increase in s-IL6R) was associated with reduced risk of CD (odds ratio 0.876; 95% confidence interval 0.822-0.933; P = .00003) or UC (odds ratio 0.932; 95% confidence interval 0.875-0.996; P = .036). These findings indicate that therapeutics designed to block IL6R signaling might be effective in treatment of IBD.
引用
- Parisinos CA, Serghiou S, Katsoulis M, et al. Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis. Gastroenterology. 2018. PMID: 29775600. doi:10.1053/j.gastro.2018.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。